NCT00532350View on ClinicalTrials.gov

Safety and Tolerability QAT370 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease

PHASE1CompletedINTERVENTIONAL

Enrollment

22

Participants

Timeline

Start Date

July 31, 2007

Study Completion Date

January 31, 2008

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG

QAT370

DRUG

Placebo

DRUG

Tiotropium

Trial Locations (3)

Unknown

Novartis investigative site, Berlin

Novartis Investigative site, Mannheim

Novartis Investigative site, Wiesbaden

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novartis

INDUSTRY